» Articles » PMID: 24586164

Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion Through Interference with Toll-like Receptor Signaling

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2014 Mar 4
PMID 24586164
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.

Citing Articles

Tsg101 mimicry of canonical E2 enzymes underlies its role in ubiquitin signaling.

Nyenhuis D, Watanabe S, Tjandra N, Carter C Proc Natl Acad Sci U S A. 2024; 122(1):e2419542121.

PMID: 39739800 PMC: 11725782. DOI: 10.1073/pnas.2419542121.


Research landmarks on the 60th anniversary of Epstein-Barr virus.

Zhong L, Xie C, Zhang L, Yang Y, Liu Y, Zhao G Sci China Life Sci. 2024; 68(2):354-380.

PMID: 39505801 DOI: 10.1007/s11427-024-2766-0.


Ubiquitin-Mediated Effects on Oncogenesis during EBV and KSHV Infection.

Mund R, Whitehurst C Viruses. 2024; 16(10).

PMID: 39459858 PMC: 11512223. DOI: 10.3390/v16101523.


Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis.

Otalora-Otalora B, Payan-Gomez C, Lopez-Rivera J, Pedroza-Aconcha N, Aristizabal-Guzman C, Isaza-Ruget M Front Cell Infect Microbiol. 2024; 14:1425388.

PMID: 39228892 PMC: 11368877. DOI: 10.3389/fcimb.2024.1425388.


Cytokine Storm Syndromes Associated with Epstein-Barr Virus.

Verbist K, Nichols K Adv Exp Med Biol. 2024; 1448:227-248.

PMID: 39117818 DOI: 10.1007/978-3-031-59815-9_16.


References
1.
Iwasaki A, Medzhitov R . Regulation of adaptive immunity by the innate immune system. Science. 2010; 327(5963):291-5. PMC: 3645875. DOI: 10.1126/science.1183021. View

2.
Casrouge A, Zhang S, Eidenschenk C, Jouanguy E, Puel A, Yang K . Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 2006; 314(5797):308-12. DOI: 10.1126/science.1128346. View

3.
Wang J, Loveland A, Kattenhorn L, Ploegh H, Gibson W . High-molecular-weight protein (pUL48) of human cytomegalovirus is a competent deubiquitinating protease: mutant viruses altered in its active-site cysteine or histidine are viable. J Virol. 2006; 80(12):6003-12. PMC: 1472576. DOI: 10.1128/JVI.00401-06. View

4.
Whitehurst C, Ning S, Bentz G, Dufour F, Gershburg E, Shackelford J . The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity. J Virol. 2009; 83(9):4345-53. PMC: 2668490. DOI: 10.1128/JVI.02195-08. View

5.
Gredmark-Russ S, Isaacson M, Kattenhorn L, Cheung E, Watson N, Ploegh H . A gammaherpesvirus ubiquitin-specific protease is involved in the establishment of murine gammaherpesvirus 68 infection. J Virol. 2009; 83(20):10644-52. PMC: 2753118. DOI: 10.1128/JVI.01017-09. View